drugset / Trial / NCT02356913

Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum

NCT02356913

Phase 1 Completed 15 enrolled Fertin Pharma A/S
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to compare the pharmacokinetic (PK) profiles and assess bioequivalence between three new nicotine gum formulations and a reference nicotine gum in healthy smokers.

Timeline

Start
2014-04
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 4 mg Oral

Indications

No indication recorded.